Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination
- PMID: 33103061
- PMCID: PMC7568689
- DOI: 10.1007/s42399-020-00588-3
Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination
Abstract
Globally, the World Health Organization (WHO) estimates that 71 million people have chronic hepatitis C virus (HCV) infection. A significant number of these will develop cirrhosis or liver cancer. Currently, during the COVID-19 outbreak, a high mortality rate has been found in patients with COVID-19 and cirrhosis. New direct-acting antiviral agents can cure more than 90% of HCV-infected patients. The new WHO strategy has introduced global goals against viral hepatitis, including a 30% reduction in new HCV cases and a 10% reduction in mortality by 2020. HCV transmission has changed considerably, reflecting both the evolution of medicine and health and social changes. The HCV is usually spread through blood-to-blood contact. After the discovery of HCV in 1989, antibody screening has drastically decreased the incidence of post-transfusion hepatitis. Nowadays, routine blood donor screening by nucleic acid amplification testing for the presence of HCV RNA has been introduced in many countries. It is conceivable that HCV screening could be offered to people born between 1946 and 1964 in the developed world and to people at high risk for HCV infection such as those who have received blood transfusions, blood products or organ donations before the 1990s, prisoners, health care workers, drug users and infants born to HCV-infected women. To achieve HCV elimination, health programmes should include improvement to access to health care services, increased screening and new projects to identify a submerged portion of patients with HCV infection. Submerged people with HCV infection are both people who are unaware of their condition and people diagnosed with HCV but not yet treated. Based on these premises, this review will examine and discuss the epidemiological changes in contracting HCV, highlighting the ways in which to identify a submerged portion of patients with HCV infection.
Keywords: COVID-19; Epidemiology; Hepatitis C virus; Public health; Screening.
© Springer Nature Switzerland AG 2020.
Conflict of interest statement
Competing InterestsThe authors declare that they have no competing interests.
Figures
References
-
- World Health Organization. Hepatitis C. 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Accessed 27 July 2020.
-
- Centers for Disease Control and Prevention. Hepatitis C questions and answers for health professionals. 2020. Available at : https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm. Accessed 7 Aug 2020.
-
- Dirks M, Haag K, Pflugrad H, Tryc AB, Schuppner R, Wedemeyer H, Potthoff A, Tillmann HL, Sandorski K, Worthmann H, Ding X, Weissenborn K. Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. J Viral Hepat. 2019;26:422–431. doi: 10.1111/jvh.12979. - DOI - PubMed
-
- Zignego AL, Ferri C, Pileri SA. Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV infection. Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007;39:2–17. doi: 10.1016/j.dld.2006.06.008. - DOI - PubMed
-
- World Health Organization. WHO urges countries to invest in eliminating hepatitis. 2019. Available at: https://www.who.int/news-room/detail/26-07-2019-who-urges-countries-to-i.... Accessed 26 July 2019.
Publication types
LinkOut - more resources
Full Text Sources